DT-PACE regimen: Difference between revisions
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AV}} | {{CMG}}; {{AE}} {{AV}} | ||
{{SK}}Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen; DT-PACE Regimen | {{SK}} Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen; DT-PACE Regimen | ||
==Overview== | ==Overview== | ||
Line 10: | Line 10: | ||
==Regimen== | ==Regimen== | ||
{{chemo|D|Dexamethasone}} | {{chemo|D|Dexamethasone}} | ||
Line 24: | Line 23: | ||
==Indications== | ==Indications== | ||
*Relapsed and refractory [[multiple myeloma]]<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63501}}</ref> | *Relapsed and refractory [[multiple myeloma]]<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63501}}</ref> | ||
Latest revision as of 03:23, 13 March 2015
WikiDoc Resources for DT-PACE regimen |
Articles |
---|
Most recent articles on DT-PACE regimen Most cited articles on DT-PACE regimen |
Media |
Powerpoint slides on DT-PACE regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on DT-PACE regimen at Clinical Trials.gov Trial results on DT-PACE regimen Clinical Trials on DT-PACE regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on DT-PACE regimen NICE Guidance on DT-PACE regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on DT-PACE regimen Discussion groups on DT-PACE regimen Patient Handouts on DT-PACE regimen Directions to Hospitals Treating DT-PACE regimen Risk calculators and risk factors for DT-PACE regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for DT-PACE regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen; DT-PACE Regimen
Overview
DT-PACE regimen refers to a regimen consisting of dexamethasone, thalidomide (DT) and cisplatin, doxorubicin, cyclophosphamide and etoposide (PACE) used for the treatment of relapsed and refractory multiple myeloma.[1]
Regimen
DDexamethasone
TThalidomide
PCisplatin
ADoxorubicin (Adriamycin)
CCyclophosphamide
EEtoposide
Indications
- Relapsed and refractory multiple myeloma[2]